Adriana Feder, MD
- PROFESSOR | Psychiatry
Research Topics:Stress, Trauma
Dr. Feder is Associate Professor of Psychiatry and Associate Director for Research at the World Trade Center Mental Health Program at the Icahn School of Medicine at Mount Sinai. She is also an investigator at the Mood and Anxiety Disorders Program (MAP). Her research spans clinical, epidemiological and translational studies of resilience and posttraumatic stress in a range of trauma-exposed populations, including World Trade Center (WTC) rescue and recovery workers, earthquake survivors, and survivors of interpersonal violence. Dr. Feder has been Principal Investigator (PI) of CDC/NIOSH-funded studies on the longitudinal course and biomarkers of PTSD and resilience in WTC responders, and has been awarded a NARSAD Independent Investigator Award from the Brain and Behavior Research Foundation to conduct a randomized controlled trial of repeated ketamine administration for PTSD.
Financial & Billing Information
Please direct any detailed billing or financial inquires to the Mount Sinai Psychiatry billing customer service number at 212-659-8752.
- Adjustment Disorder
- Generalized Anxiety Disorder
- Panic Disorder
- Post-Traumatic Stress Disorder
- Postpartum Depression
- Premenstrual Dysphoric Disorder
- Seasonal Affective Disorder
- Social Anxiety Disorder
Residency, Psychiatry, University of California San Francisco
Fellowship, Psychiatry, University of California San Francisco
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Feder did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.